"immunoluminescent" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "immuno",
        "3": "luminescent"
      },
      "expansion": "immuno- + luminescent",
      "name": "prefix"
    }
  ],
  "etymology_text": "immuno- + luminescent",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "immunoluminescent (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with immuno-",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015, Macanori Odashiro et al., “Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma*”, in Anais Brasileiros de Dermatologia, volume 90, →DOI",
          "text": "Most studies on these markers have demonstrated that MIA has better sensitivity and prognostic potential than S100. 30, 31 Moreover, most of these studies have measured S100 using immunoradiometric and immunoluminescent assays or polymerase chain reaction (PCR). 32 - 34 We know that the ELISA test is routinely used in most clinical laboratories throughout Brazil, as its application is very broad and ranges from oncology to mycology. 35, 36 However, PCR and the other aforementioned assays are more specialized and may not be present in all laboratories, while ELISA is.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Relating to, or employing immunoluminescence"
      ],
      "id": "en-immunoluminescent-en-adj-P4UWBWe2",
      "links": [
        [
          "immunoluminescence",
          "immunoluminescence"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "immunoluminescent"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "immuno",
        "3": "luminescent"
      },
      "expansion": "immuno- + luminescent",
      "name": "prefix"
    }
  ],
  "etymology_text": "immuno- + luminescent",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "immunoluminescent (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with immuno-",
        "English terms with quotations",
        "English uncomparable adjectives"
      ],
      "examples": [
        {
          "ref": "2015, Macanori Odashiro et al., “Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma*”, in Anais Brasileiros de Dermatologia, volume 90, →DOI",
          "text": "Most studies on these markers have demonstrated that MIA has better sensitivity and prognostic potential than S100. 30, 31 Moreover, most of these studies have measured S100 using immunoradiometric and immunoluminescent assays or polymerase chain reaction (PCR). 32 - 34 We know that the ELISA test is routinely used in most clinical laboratories throughout Brazil, as its application is very broad and ranges from oncology to mycology. 35, 36 However, PCR and the other aforementioned assays are more specialized and may not be present in all laboratories, while ELISA is.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Relating to, or employing immunoluminescence"
      ],
      "links": [
        [
          "immunoluminescence",
          "immunoluminescence"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "immunoluminescent"
}